BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 15960298)

  • 1. Enhanced pressor response to centrally administered vasopressin in WKY rats on high sodium diet.
    Zera T; Ufnal M
    Acta Neurobiol Exp (Wars); 2005; 65(2):145-50. PubMed ID: 15960298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased pressor function of central vasopressinergic system in hypertensive renin transgenic rats.
    Szczepańska-Sadowska E; Paczwa P; Loń S; Ganten D
    J Hypertens; 1998 Oct; 16(10):1505-14. PubMed ID: 9814623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Central V1 AVP receptors are involved in cardiovascular adaptation to hypovolemia in WKY but not in SHR.
    Budzikowski AS; Paczwa P; Szczepańska-Sadowska E
    Am J Physiol; 1996 Sep; 271(3 Pt 2):H1057-64. PubMed ID: 8853341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Centrally applied vasopressin intensifies hypotension and bradycardia after hemorrhage in shr rats.
    Dobruch J; Paczwa P; Loń S; Szczepańska-Sadowska E
    J Physiol Pharmacol; 2002 Jun; 53(2):295-8. PubMed ID: 12120904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancement of central pressor effect of AVP in SHR and WKY rats by intracranial N(G)-nitro-L-arginine.
    Paczwa P; Budzikowski AS; Szczepańska-Sadowska E
    Brain Res; 1997 Feb; 748(1-2):51-61. PubMed ID: 9067444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Centrally administered interleukin-1 beta sensitizes to the central pressor action of angiotensin II.
    Ufnal M; Dudek M; Zera T; Szczepańska-Sadowska E
    Brain Res; 2006 Jul; 1100(1):64-72. PubMed ID: 16765325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential effects of V2 vasopressin agonist and antagonists on blood pressure regulation in normotensive (WKY) and spontaneously hypertensive (SHR) rats.
    Budzikowski A; Lon S; Paczwa P; Szczepanska-Sadowska E
    J Auton Nerv Syst; 1992 Jun; 39(2):87-95. PubMed ID: 1430797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma vasopressin concentration in high sodium renal hypertension.
    Hinojosa C; Shade RE; Haywood JR
    J Hypertens; 1986 Oct; 4(5):529-34. PubMed ID: 3794328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of high sodium renal hypertension during chronic blockade of the vascular effects of vasopressin.
    Hinojosa C; Haywood JR
    J Pharmacol Exp Ther; 1986 Aug; 238(2):492-6. PubMed ID: 2874211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolonged stimulation of intrarenal V1 vasopressin receptors results in sustained hypertension.
    Szczepanska-Sadowska E; Stepniakowski K; Skelton MM; Cowley AW
    Am J Physiol; 1994 Nov; 267(5 Pt 2):R1217-25. PubMed ID: 7977848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Central cardiovascular effects of AVP and ANP in normotensive and spontaneously hypertensive rats.
    Stepniakowski K; Budzikowski A; Loń S; Szczepańska-Sadowska E
    J Auton Nerv Syst; 1994 Apr; 47(1-2):33-43. PubMed ID: 8188982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced cold pressor response in spontaneously hypertensive rats on high-NaCl diet.
    Thornton RM; Davidson JM; Oparil S
    Am J Physiol; 1988 Nov; 255(5 Pt 2):H1018-23. PubMed ID: 3189566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Attenuation of spontaneous hypertension in rats by a vasopressin antagonist.
    Sladek CD; Blair ML; Sterling C; Mangiapane ML
    Hypertension; 1988 Nov; 12(5):506-12. PubMed ID: 3056858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of vasopressin and V1 receptors blockade on blood pressure and heart rate in spontaneously hypertensive rats.
    Stepniakowski K; Lapiński M; Noszczyk B; Januszewicz A; Szczepańska-Sadowska E
    Pol J Pharmacol Pharm; 1991; 43(6):487-93. PubMed ID: 1840331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Central and systemic effects of a vasopressin V1 antagonist on MAP recovery after haemorrhage in rats.
    Johnson JV; Bennett GW; Hatton R
    J Cardiovasc Pharmacol; 1988 Oct; 12(4):405-12. PubMed ID: 2465440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of vasopressin and V1 receptors blockade on hypotensive action of ANP in normotensive (WKY) and spontaneously hypertensive rats.
    Lapiński M; Stepniakowski K; Januszewicz A; Noszczyk B; Szczepańska-Sadowska E
    J Physiol Pharmacol; 1992 Mar; 43(1):65-78. PubMed ID: 1450435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential effects of centrally injected AVP on heart rate, core temperature, and behavior in rats.
    Diamant M; De Wied D
    Am J Physiol; 1993 Jan; 264(1 Pt 2):R51-61. PubMed ID: 8430886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Central ANP attenuates pressor responses to central AVP in WKY and SHR.
    Stepniakowski K; Budzikowski A; Lon S; Szczepanska-Sadowska E
    Brain Res Bull; 1991 Aug; 27(2):247-9. PubMed ID: 1835898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Responses of vasopressin, atrial natriuretic peptide, and blood pressure to central osmotic stimulation.
    Iitake K; Kimura T; Ota K; Shoji M; Inoue M; Ohta M; Sato K; Yamamoto T; Yasujima M; Abe K
    Am J Physiol; 1989 Oct; 257(4 Pt 1):E611-6. PubMed ID: 2529777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced pressor response in spontaneously hypertensive rats induced by stimulation of vasopressin-V1 receptors.
    Yamauchi T; Ogura T; Oishi T; Harada K; Hashimoto M; Mimura Y; Asano N; Ota Z; Kageyama J
    Acta Med Okayama; 1995 Feb; 49(1):53-9. PubMed ID: 7762410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.